The Japanese Pharmacopoeia (JP) is a publication by the MinistryofHealth, Labour and Welfare (MHLW) in Japan.
It serves as the officialstandard for the quality, purity, and identity of pharmaceutical substances and products in Japan.
The 18th edition came into effect on 07 June 2021. Supplement I to JP18 was published in 2022, and Supplement II in 2024
- The English Version of the Japanese Pharmacopoeia is published for the convenience of users unfamiliar with the Japanese language. When and if any discrepancy arises between the Japanese original and its English translation, the former is authentic.
[Japan Minister of Health, Labour and Welfare]
